Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Depreciation & Amortization (CF): 2020-2025

Historic Depreciation & Amortization (CF) for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $2.7 million.

  • Cellebrite DI's Depreciation & Amortization (CF) rose 3.09% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 1.54%. This contributed to the annual value of $10.6 million for FY2024, which is 5.95% up from last year.
  • Cellebrite DI's Depreciation & Amortization (CF) amounted to $2.7 million in Q3 2025, which was up 4.28% from $2.6 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Depreciation & Amortization (CF) high stood at $2.7 million for Q4 2024, and its period low was $1.5 million during Q1 2021.
  • Its 3-year average for Depreciation & Amortization (CF) is $2.6 million, with a median of $2.6 million in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 42.51% in 2022, then dropped by 1.83% in 2025.
  • Over the past 5 years, Cellebrite DI's Depreciation & Amortization (CF) (Quarterly) stood at $1.8 million in 2021, then spiked by 38.92% to $2.5 million in 2022, then climbed by 3.77% to $2.6 million in 2023, then increased by 4.36% to $2.7 million in 2024, then rose by 3.09% to $2.7 million in 2025.
  • Its Depreciation & Amortization (CF) was $2.7 million in Q3 2025, compared to $2.6 million in Q2 2025 and $2.6 million in Q1 2025.